Research indicates biotin may impair lab test accuracy in cancer patients — Evidence Review

Hair loss supplements like biotin are widely used by cancer patients hoping to restore hair after treatment, but a new study highlights that biotin not only lacks clear evidence for effectiveness in this context, it can also interfere with key cancer monitoring blood tests. Most related studies focus on biotin’s potential for targeted cancer therapies, but they do not address the risks of biotin supplements affecting laboratory results, so this new finding fills an important gap; see the original source for more details.

• While the new study raises concerns about biotin supplements distorting lab test results during cancer care, most previous research has investigated biotin as a drug delivery or imaging agent, targeting tumors by exploiting biotin receptor overexpression on cancer cells, rather than its effects on systemic lab test accuracy 1 2 3 4 5 11 13 14.
• Several related studies confirm that biotin is commonly used in biochemical assays and can form stable complexes with proteins, suggesting a plausible mechanism for interference in laboratory measurements, though direct clinical evidence of harm in cancer monitoring has been limited until now 1 6.
• There is general agreement that biotin deficiency is rare, and supplementation rarely confers significant benefits for hair or nail growth in healthy or even cancer-affected populations, aligning with the new findings that routine biotin use may be unnecessary and potentially problematic for cancer patients 7.

Study Overview and Key Findings

Cancer treatment-induced hair loss is a distressing side effect for many patients, prompting widespread interest in over-the-counter supplements like biotin. Despite its popularity, the new study from The Ohio State University Comprehensive Cancer Center raises safety concerns, especially regarding biotin’s potential to distort critical blood test results used in cancer monitoring and management. The study emphasizes the need for clinicians and patients to openly discuss hair loss and supplement use, particularly since many patients may self-prescribe biotin without understanding the implications for their ongoing cancer care.

Property	Value
Organization	The Ohio State University Comprehensive Cancer Center, The Ohio State University College of Medicine
Journal Name	JCO Oncology Practice
Authors	Brittany Dulmage
Population	Cancer patients experiencing hair loss
Outcome	Impact of biotin on hair loss and lab test accuracy
Results	Biotin may cause inaccurate lab results affecting treatment plans.

Literature Review: Related Studies

To provide a broader perspective, we searched the Consensus database, which includes over 200 million research papers, for studies related to biotin, cancer treatment, and laboratory test accuracy. The following search queries were used:

1. biotin impact cancer treatment accuracy
2. vitamin effects laboratory test results
3. biotin interference cancer care protocols

Below is a summary of related research grouped by key topics:

Topic	Key Findings
How does biotin interact with cancer cells, and what is its role in targeted therapy?	- Biotin conjugates and nanoparticles can facilitate targeted drug delivery to tumors due to overexpression of biotin receptors on cancer cells, enhancing drug efficacy and selectivity 1 2 3 4 5 11 13 14. - Biotinylated molecules are used for imaging and therapy, but these approaches focus on biotin as a delivery vector, not as a dietary supplement 1 2 4 5 11.
Does biotin supplementation affect laboratory test accuracy in clinical settings?	- Biotin can interfere with immunoassays and certain laboratory tests, potentially leading to erroneous results, particularly when high-dose supplements are used 1 6 8. - Effects of other vitamins (e.g., vitamin C) on lab results have been documented, supporting the plausibility of interference by supplements in clinical diagnostics 6 8.
What is the prevalence and impact of biotin deficiency, and are supplements beneficial for hair/nails?	- Biotin deficiency is uncommon in the general population, and both natural and synthetic vitamin B complexes (including biotin) show similar bioavailability, with limited evidence supporting benefits for hair or nail health in well-nourished individuals 6 7. - Most people obtain adequate biotin from diet, and supplementation rarely addresses true deficiencies or leads to measurable clinical improvements 6 7.
What are the challenges of measuring vitamins and biomarkers in clinical laboratories?	- Laboratory measurement of vitamins and nutritional biomarkers faces challenges, including interference from supplements and high variability across testing methods 9 10. - External quality assessment programs reveal persistent issues in assay performance and consistency, which can be exacerbated by supplement use 9 10.

How does biotin interact with cancer cells, and what is its role in targeted therapy?

Numerous studies have explored the use of biotin as a targeting ligand for cancer therapeutics and diagnostics. These approaches exploit the tendency of cancer cells to overexpress biotin receptors, thereby allowing biotin-conjugated nanoparticles or drugs to selectively accumulate in tumor tissues. While these findings underscore biotin’s utility in cancer research, they pertain primarily to engineered drug delivery systems, not to oral biotin supplementation as addressed in the new study.

• Biotin-conjugated drugs and nanoparticles show increased uptake and efficacy in cancer cells overexpressing biotin receptors, improving selectivity and reducing toxicity to healthy tissues 1 2 3 4 5 11 13 14.
• Biotin conjugation has been used for live-cell imaging and biosensing in cancer models, capitalizing on biotin’s strong binding to avidin/streptavidin 1.
• Several studies report that multifunctional nanoparticles targeting both biotin and other cancer markers can further enhance tumor selectivity 11 14.
• These findings are largely confined to experimental or preclinical settings, and do not address the effects of dietary biotin or supplements on cancer outcomes 1 2 3 4 5 11 13 14.

Does biotin supplementation affect laboratory test accuracy in clinical settings?

The new study’s primary concern—that biotin supplementation can interfere with laboratory assays used in cancer care—finds indirect support in several related studies. While most research focuses on biotin’s role as a reagent or label in biochemical assays, there is evidence that high levels of biotin can disrupt test accuracy, paralleling similar effects observed with other vitamins.

• Biotin’s high affinity for avidin/streptavidin is foundational to many immunoassays, making interference from excess biotin a recognized risk 1.
• Documented interference by vitamins (including biotin and vitamin C) in laboratory tests highlights the need for clinical awareness of supplement use 6 8.
• Such interference can result in false readings of hormones and biomarkers, potentially impacting diagnosis and treatment, as seen with vitamin C and other nutrients 8.
• This topic is underrepresented in the clinical literature, making the new study an important contribution to patient safety and laboratory best practices 1 6 8.

What is the prevalence and impact of biotin deficiency, and are supplements beneficial for hair/nails?

Evidence from nutritional research consistently indicates that biotin deficiency is rare in the general population, including among cancer patients without specific risk factors. Supplementation with biotin or vitamin B complexes does not appear to offer substantial benefits for hair or nail growth in well-nourished individuals.

• Biotin is widely available in foods, and clinical deficiency is uncommon except in special circumstances 6.
• Studies comparing natural and synthetic vitamin B complexes show similar bioavailability and no major differences in health outcomes, including biomarkers relevant to hair or skin 7.
• There is little published evidence supporting widespread use of biotin supplements for hair loss, especially when deficiency is not present 7.
• The new study aligns with this consensus, advising against routine supplementation in cancer survivors unless medically indicated 6 7.

What are the challenges of measuring vitamins and biomarkers in clinical laboratories?

Ensuring accurate measurement of vitamins and other biomarkers is a persistent challenge in clinical laboratories, complicated by the presence of supplements and method variability. Studies emphasize the importance of standardization and awareness of potential assay interference.

• Variability in laboratory performance and methods affects the reliability of vitamin and biomarker measurements, with supplements like biotin introducing additional complexity 9 10.
• External quality assessment reveals that many laboratories struggle to maintain consistent accuracy, particularly for certain vitamins 10.
• Interference from structurally similar metabolites, as well as supplemental intake, can lead to erroneous interpretation of test results 9.
• The new study’s findings further highlight the need for clinicians and laboratorians to be aware of patient supplement use during diagnostic testing 9 10.

Future Research Questions

As biotin supplementation becomes increasingly common among cancer survivors and the broader population, further research is needed to clarify its clinical impact, particularly regarding laboratory test interference and actual benefits. The following research questions highlight important areas for future investigation:

Research Question	Relevance
How frequently does biotin supplementation cause clinically significant errors in cancer monitoring laboratory tests?	Understanding the true incidence of biotin-induced test interference will help clinicians assess the magnitude of the risk and inform patient guidance 1 6 8.
Are there specific patient populations at greater risk for biotin-related lab test interference during cancer treatment?	Identifying at-risk groups (e.g., those on high-dose supplements or with certain cancer types) could target educational and clinical interventions more effectively 1 8.
What is the minimum biotin dose that causes measurable interference with common cancer biomarker assays?	Establishing dose thresholds for interference will support evidence-based guidance on supplement discontinuation before laboratory testing 1 8.
Does cessation of biotin supplements prior to testing fully eliminate the risk of lab errors in cancer patients?	Investigating the optimal washout period and the persistence of biotin’s effects is crucial for developing safe laboratory protocols 1 8.
Are there safe and effective alternatives to biotin for managing hair loss in cancer survivors?	Given the lack of evidence for biotin’s benefit and the potential risks, research into alternative therapies (such as topical minoxidil) is needed to support patient quality of life 7.

---

In summary, while biotin holds promise as a targeting agent in experimental cancer therapies, its widespread use as a supplement for hair loss in cancer survivors is not supported by strong evidence and may pose risks to the accuracy of critical laboratory tests. Dialogue between patients and clinicians about supplement use is essential, and further research is needed to clarify best practices for safe and effective care.